Skip to main navigation Skip to search Skip to main content

North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane

  • Kostandinos Sideras
  • , Amylou C. Dueck
  • , Timothy J. Hobday
  • , Kendrith M. Rowland
  • , Jacob B. Allred
  • , Donald W. Northfelt
  • , Wilma L. Lingle
  • , Robert J. Behrens
  • , Tom R. Fitch
  • , Daniel A. Nikcevich
  • , Edith A. Perez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science